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OBJECTIVE — Upto30%ofwomenwithrecentgestationaldiabetesmellitus(GDM)remain
glucose intolerant after delivery. However, the rate of postpartum oral glucose tolerance tests
(ppOGTTs) is low. Our aim in this study was to develop a model for risk assessment to target
women with high risk for postpartum diabetes.
RESEARCH DESIGN AND METHODS — In 605 Caucasian women with GDM, ante-
natal obstetrical and glucose data and the glucose data of the ppOGTTs performed 13 weeks
(median) after delivery were prospectively collected.
RESULTS — A total of 132 (21.8%) women had an abnormal ppOGTT (2.8% impaired
fastingglucose,13.6%impairedglucosetolerance,and5.5%diabetes).Independentriskfactors
were BMI 30 kg/m
2 (prevalence of abnormal ppOGTT 36.0 vs. 17.3%), gestational age at
diagnosis 24 weeks (32.4 vs. 18.0%), 1-h antenatal value 200 mg/dl (11.1 mmol/l) (35.2 vs.
14.8%), and insulin therapy (30.3 vs. 14.5%). The prevalence of an abnormal ppOGTT was
assessed according to the number of risk factors: 0, 9.2% (14 of 153); 1, 13.4% (25 of 186); 2,
28.5% (43 of 151); 3, 45.6% (26 of 57); and 4, 68.4% (13 of 19). Subjects were divided
according to a signiﬁcant increase of prevalence and risk for a ppOGTT: low risk (59.9% of
subjects), 2 risk factors, 11.6%, odds ratio 1.3; intermediate risk, 2 risk factors, 28.5%, 4.0;
and high risk, 2 risk factors, 51.3%, 10.5. The intermediate/high-risk group included 86.6%
of those with diabetes and 67% of all those with abnormal ppOGTTs.
CONCLUSIONS — Womenwith2riskfactorshaveahighriskforanabnormalppOGTT,
and86%ofpostpartumdiabetesisdiagnosedwithinthisgroup.TargetingwomenforppOGTTs
based on a risk assessment using available antenatal risk factors might reduce the number of
missed cases of postpartum diabetes.
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G
estational diabetes mellitus (GDM)
implies a substantial risk of later di-
abetes. Diabetes rates are reported
to be between 9 and 43% within 5–10
years after the index pregnancy (1–4),
and the incidence of diabetes in women
after GDM pregnancies appears to be in-
creasing (2). There is evidence that in
women with GDM an underlying preex-
isting -cell defect is demasked by poor
pancreatic -cell compensation for phys-
iological insulin resistance in pregnancy.
The prevalence of diabetes within 1 year
after delivery in women with recent GDM
is reported to vary between 3 and 24%
(3,4), depending on the population char-
acteristics, timing of postpartum testing,
and applied diagnostic criteria for diabe-
tes outside pregnancy.
Recommendations of the 5th Work-
shop-Conference on GDM (5) are that
women with GDM undergo postpartum
glucose tolerance testing with an oral glu-
cose tolerance test (OGTT) at 6–12
weeks, 1 year after delivery, and every 3
yearsthereafter.Therationalforthisrecom-
mendationisbasedonthepotentialtoiden-
tify women with apparent diabetes as well
as women with impaired glucose tolerance
(IGT) in whom diabetes can be delayed or
prevented by lifestyle intervention or mod-
erate drug therapy (6).
Inreality,theratesofpostpartumglu-
cosetestingarelowanddependentonthe
compliance of caregivers and patients (7–
10). Testing is complicated by disconti-
nuity of care after delivery and mothers
underestimating their diabetes risk and
stress to adapt to the challenge of caring
for a young baby. More exact quantiﬁca-
tionoftheindividualriskfordiabetesand
targetingwomenathighriskmayincrease
the compliance and efﬁcacy not to miss
women with postpartum persistent glu-
cose intolerance. Several risk factors had
been identiﬁed for an increased risk for
persistent glucose intolerance in the 1st
year after delivery (10–15). The aim of
our study was to use the knowledge of
risk factors to develop a model for risk
stratiﬁcation based on the combination of
antenatal risk factors that might allow us
to distinguish between women with high,
intermediate, or low risk for postpartum
diabetes within 1 year after GDM.
RESEARCH DESIGN AND
METHODS— For this prospective
multicenter study, data from Caucasian
women whose GDM was diagnosed from
1 January 2000 through December 2005
from three different German institutions
with diabetes and pregnancy specialist ser-
vices were analyzed. Those services were 1)
the Clinic of Diabetes at the Department of
Obstetrics of the Vivantes Medical Center,
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Diabetology at the University Medical Cen-
terofBonn,and3)aprivateclinicthatisrun
by two diabetologists in Kiel.
The women were selected from an
ongoingdatabaseinwhichclinical,glyce-
mic,anddeliverydataforallwomenwere
prospectively entered. Inclusion criteria
for this study were 1) maternal glucose
intolerance ﬁrst diagnosed in pregnancy,
2) availability of clinical data regarding
maternal characteristics, glycemic data,
and neonatal parameters, and 3) a docu-
mented maternal postpartum OGTT
(ppOGTT) within 1 year of delivery. The
studyprotocolwasapprovedbylocaleth-
icscommittees.Informedconsentwasob-
tained from the women at the time of
ppOGTT.
Diabetes care and postpartum
testing
Diabetes care was uniformly managed at
all sites by a standardized management
protocol based on German guidelines for
diagnosis and therapy of GDM derived
from the recommendations of the 5th
Workshop-Conference on GDM (5). Di-
agnosis of glucose intolerance was estab-
lished by a 2-h 75-g OGTT performed
between 24 and 28 weeks of gestation. In
women with a high risk for diabetes, test-
ing was done earlier. According to the
policy in Germany at the time of the
study, GDM testing was focused on
women with risk factors for GDM. After
GDM diagnosis, women were given di-
etary instructions and advised to perform
blood glucose monitoring with glucose
proﬁles and preprandial and 2-h post-
prandial measurements twice a week or
daily using memory-based glucometers if
insulin therapy was required. Insulin
therapy was initiated when either the av-
erage glucose value of a proﬁle exceeded
100 mg/dl (5.5 mmol/l) or a fasting glu-
cose value 95 mg/dl (5.3 mmol/l)
and/or 2-h postprandial value 120
mg/dl (6.6 mmol/l) was seen after a
2-week trial of diet (5).
In women with GDM requiring insu-
lin, at least one glucose proﬁle was per-
formed before hospital discharge, and
patients with fasting capillary whole
blood glucose 110 mg/dl (6.1 mmol/l)
and 2-h postprandial glucose 160
mg/dl (8.8 mmol/l) were asked to con-
tinue glucose testing and were scheduled
for a visit to the diabetes clinic 1 week
after discharge. All remaining women
were offered an OGTT within 6–12
weeks after delivery. Diabetes was diag-
nosed by either fasting venous plasma
glucose126mg/dl(7.0mmol/l)ora2-h
value 200 mg/dl (11.1 mmol/l), im-
paired fasting glucose (IFG) tolerance by
fastingglucose110mg/dl(6.1mmol/l),
and IGT by 2-h glucose 140 mg/dl (7.7
mmol/l) (16).
Data collection and statistical
analysis
Antenatal maternal clinical, glycemic, de-
livery, neonatal, and ppOGTT data were
derived from the database of each institu-
tion.Neonatalmacrosomiawasdeﬁnedas
birth weight 90th percentile derived
from a German national survey (17). As a
primary measure of outcome, ppOGTT
data diagnosed as IFG, IGT, or diabetes
were combined to create a binary variable
coded as abnormal. An OGTT fulﬁlling
the criteria of both IFG and IGT was clas-
siﬁed as IGT. Women with repeat ele-
vated results in the postpartum glucose
proﬁles (performed because of insulin-
requiring GDM) were included in the
groupwithabnormalpostpartumglucose
toleranceandwereassignedtothegroups
mentioned above, depending on the ele-
vated values in the proﬁles.
Variables considered as potentially
predictiveforanabnormalppOGTTwere
analyzedwiththestatisticalpackageSPSS
12.0 (SPSS, Chicago, IL). Data are pre-
sentedasnumbersandproportionforcat-
egorical variables or as means  SD for
continuous variables, respectively. Ac-
cordingly, a Pearson 
2 test or two-sided
Mann-Whitney U test was used to test for
differences between women with normal
or abnormal ppOGTT. Differences with
P  0.05 were regarded as statistically
signiﬁcant.
Forward stepwise multivariate logis-
tic regression analysis including all signif-
icant parameters from the univariate
analysis was performed to identify inde-
pendent predictors of an abnormal
ppOGTT termed as risk factors. For this
reason, variables were dichotomized ac-
cording to conventionally used thresh-
olds and/or statistical considerations
(e.g., BMI 30 kg/m
2 or antenatal 1-h
OGTT 200 mg/dl). Results for each risk
factor are presented as odds ratios (ORs)
with 95% CI. Furthermore, based on the
number of risk factors identiﬁed for each
subject, the prevalence of an abnormal
ppOGTT was assessed and used for the
stratiﬁcation of the study cohort into
threegroupsaccordingtolow,intermedi-
ate,orhighriskofanabnormalppOGTT,
respectively.
RESULTS— In 1,184 women (Kiel
331, Bonn 336, and Berlin 517) with
GDM, the overall return rate for postpar-
tumtestingwas51.1%(Kiel79.9%,Bonn
65.0%, and Berlin 23.4%). At the Berlin
site, the lowest return rate of 13% was
seen in women with Turkish or Arabian
background who accounted for 32.8% of
the population. A total of 605 women
(Kiel 265, Bonn 219, and Berlin 121) ful-
ﬁlled the inclusion criteria and qualiﬁed
fortheanalysis.ppOGTTwasfoundtobe
abnormalin132women(21.8%)andwas
classiﬁed as IFG in 17 (2.8%) and as IGT
in 82 (13.6%); 33 women (5.5%) had di-
abetes. Diagnosis was based on abnormal
glucose proﬁles in 17 women within 1
week after discharge. The rate of abnor-
mal ppOGTT was similar in two of the
participating centers (Kiel 17.7% and
Bonn 21.5%) but was signiﬁcantly ele-
vated in the third center (Berlin 31.4%,
P0.027).Byunivariateanalyses,signif-
icant differences between women with
normal and abnormal ppOGTTs were
found for prepregnancy BMI, gestational
age at diagnosis, all glucose values for the
antenatal OGTT, gestational age at deliv-
ery, insulin therapy, and neonatal macro-
somia (Table 1).
ThestudysiteinBerlinhadaverylow
return rate. To exclude a possible selec-
tion bias by overrepresentation of women
at highest risk, we compared returners
and nonreturners at this study site. There
was no signiﬁcant difference in maternal
characteristics, glycemic parameters, or
insulin use (31.0 vs. 32.8%) besides the
2-h OGTT value (154.9 vs. 146.4 mg/dl,
P  0.02).
In 566 subjects (93.6%), complete
datasets for multivariate analysis were
available. We found four independent
risk factors: prepregnancy BMI 30
kg/m
2 (prevalence of abnormal ppOGTT
36.0 vs. 17.3%), gestational age at diag-
nosis 24 weeks (32.4 vs. 18.0%), 1-h
antenatal OGTT 200 mg/dl (35.2 vs.
14.8%), and insulin therapy (30.3 vs.
14.5%). A 1-h glucose value 200 mg/dl
wasthestrongestpredictorofpostpartum
glucose intolerance (Table 2). BMI 30
kg/m
2 was present in 22.5% of the
women, gestational age at diagnosis was
24weeksin28.1%,insulintherapywas
being used in 45.8%, and a 1-h postchal-
lenge glucose value 200 mg/dl was seen
in 31.9%.
Based on the results of the analysis
above, we calculated the prevalence of an
abnormal ppOGTT according to the
number of identiﬁed risk factors present
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majority of the women (339 of 566,
59.9%) had 2 risk factors. A signiﬁcant
increase in the prevalence of abnormal
ppOGTTs was seen between 2 and 2
risk factors and between 2 and 2 risk
factors (Fig. 1). The proportion of sub-
jectswitheither2riskfactors(lowrisk),
2 risk factors (intermediate risk), or 2
risk factors (high risk), and the corre-
sponding ORs for postpartum glucose in-
tolerance are presented in Fig. 2. The
prevalence of abnormal postpartum glu-
cose tolerance was 11.5% (39 of 339) in
the low-risk group, 28.5% (43 of 151) in
the intermediate-risk group, and 51.3%
(39 of 76) in the high-risk group.
When OGTT testing is concentrated
on women with intermediate/high risk
(2 risk factors, 40.1% of subjects), a to-
tal rate of 36.1% abnormal glucose toler-
ance could be expected, compared with a
reducedrateof11.5%inwomenwith2
risk factors. Of the women with low risk,
only 4 (1.2%) had overt diabetes, in con-
trastwith25woman(11.0%)intheinter-
mediate/high-risk group. That means
85 low-risk women would need to be
tested to uncover 1 case of diabetes com-
pared with 10 women per case in the in-
termediate/high-risk women. In total,
86.2%ofcasesofovertdiabetes(25of29)
and 67.8% of all abnormal OGTTs (82 of
121) were identiﬁed within the interme-
diate/high-risk group.
CONCLUSIONS — In a large-scale,
multicenter study, we found 21% persis-
tent glucose intolerance within 1 year af-
ter a pregnancy with GDM in Caucasian
women. However, we saw that the return
rate was different at the three study sites.
We suspect that the return rate might
have been inﬂuenced by the population
composite and the care setting. Based on
identiﬁed risk factors, we developed an
algorithm for postpartum glucose testing
that allows us to target women who
should be intensively followed and moti-
vated to return for testing because of their
high risk for abnormal glucose tolerance.
A combination of 2 risk factors, which
waspresentin40%ofthepopulation,was
highly predictive for the development of
diabetes within 1 year after delivery, and
86% of diabetes would be detected.
The prevalence of abnormal glucose
testing observed in our population was
within the range reported from other
studies. The prevalence of isolated IFG
varies between 3 and 6%, the prevalence
ofIGTvariesbetween7and29%,andthe
prevalence of diabetes varies between 5
and 12% (4,7,10–13,15,18,19). Particu-
lar risk factors associated with abnormal
postpartum glucose tolerance varied
among studies, but early diagnosis of
GDM and high maternal BMI as potential
signs of preexisting insulin resistance and
insulin use as a marker of the degree of
hyperglycemia had been proven to be
predictive in most of the studies. Age,
prior GDM, family history of diabetes,
weight gain, or neonatal macrosomia of-
ten lost their predictive value when ma-
ternalglucosevalueswereincludedinthe
multivariate analysis (1,3). We identiﬁed
four independent antenatal risk factors;
besides maternal BMI 30 kg/m
2, gesta-
tional age at diagnosis 24 weeks, and
insulin use, a 1-h glucose value 200
mg/dl increased the risk by almost three-
fold. There is controversy in the literature
over whether the antenatal fasting
(7,15,20) or postchallenge values (10–
12),orboth(18),orthenumberofabnor-
mal values of an OGTT (13) is more
predictive for postpartum diabetes. Simi-
lar to our data, in one of the large studies
that included almost 3,000 women, the
1-h OGTT value was proven to be supe-
rior to the fasting glucose value (11). Re-
Table 1—Maternal characteristics and delivery data of 605 women after pregnancies with
GDM with normal and abnormal ppOGTT performed within 1 year after delivery
Normal Abnormal P*
n 473 132
History
Prior GDM (%) 14.8 19.1 0.233
Prior macrosomia (%) 5.7 7.6 0.416
Family history of diabetes (%) 56.6 60.5 0.541
Parity 2.2  1.3 2.5  1.6 0.060
Age (years) 32.7  4.5 32.2  5.6 0.651
Prepregnancy BMI (kg/m²) 25.8  5.5 28.1  6.1 0.001
Weight gain (kg) 11.9  4.6 12.6  5.1 0.457
Antenatal glucose metabolism
Gestational age at diagnosis of GDM 27.3  6.1 24.2  7.8 0.001
Insulin therapy (%) 141.0 64.1 0.001
apOGTT fasting (mg/dl) 88  14 96  20 0.001
apOGTT 1 h 191  22 211  34 0.001
apOGTT 2 h 144  31 166  41 0.001
Highest fasting glucose in proﬁles during
pregnancy (mg/dl) 87  11 90  14 0.341
Delivery
Gestational age at delivery 39.5  1.4 38.9  2.3 0.005
Macrosomia (90th percentile) (%) 8.9 16.0 0.022
ppOGTT
Time point (month pp) 3.7  3.1 5.4  6.7 0.186
ppOGTT fasting (mg/dl) 84  9 100  25 0.001
ppOGTT 1 h 148  31 199  45 0.001
ppOGTT 2 h 104  19 158  38 0.001
Data are means  SD or %. *P values (two-sided): ² test or Mann-Whitney U test, respectively. ap,
antepartum; pp, postpartum.
Table2—Independentriskfactorsforabnormalpostpartumglucosetolerancein605mothers
with GDM
Factor OR (95% CI) P
Antenatal OGTT 1 h 200 mg/dl (11.1 mmol/l) 2.73 (1.77–4.21) 0.001
Insulin therapy 2.12 (1.36–3.30) 0.001
Prepregnancy BMI 30 kg/m² 2.12 (1.33–3.40) 0.002
Gestational age at GDM diagnosis 24 weeks 1.81 (1.16–2.85) 0.010
A total of 566 datasets (93.6%) with complete parameters were used for the multiple logistic regression
analysis.
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lower postpartum insulin sensitivity in
women with an isolated abnormal 1-h
glucose value compared with those with
only elevated 2- or 3-h high values (21).
The postchallenge hyperglycemia reﬂects
the ﬁrst-phase release. Insulin clamps
during pregnancy in women with GDM
showedthatalowﬁrst-phaseintravenous
glucose tolerance test response is inde-
pendently associated with a high risk for
type 2 diabetes within 6 months after de-
livery (14).
The presence of almost 22% abnor-
mal glucose tolerance within the 1st year
after GDM underlines the importance of
early postpartum testing. Despite the
knowledge that after GDM women have a
substantial risk of staying glucose intoler-
ant or developing diabetes with the high-
est conversion rate in the 1st years after
the index pregnancy (3), physician and
patient compliance for early postpartum
glucose testing is low. Only 20% of the
obstetricians, even in an academic medi-
cal center, ordered postpartum diabetes
screening tests for their patients (22).
Withafewexceptions(11,12),moststud-
ies reported a return rate less than or
50% (7,9,10,19,23,24).
Overall, 51% of the women in our
study returned for testing, but we noted a
remarkable diversity between the study
sites that might be inﬂuenced by the so-
cial and ethnic composition of the popu-
lation. The highest recall rates were
achieved in the setting of a private clinic
in an urban middle-class population,
whereas in a community obstetrical hos-
pital in an underprivileged Berlin district
with a high rate of immigrants (41.2%)
only 23% of all women returned for test-
ingandonly13%ofwomenwithTurkish
or Arabian background returned. On the
patientside,itislikelythatdifferentover-
all health awareness and increased family
obligations in large families may contrib-
ute to low testing rates. Unfortunately, it
seems that, especially in populations with
high prevalence of postpartum glucose
intolerance, many obstacles have to be
overcome.Someofthesearerelatedtothe
health system, some are internal to the
patient, and some are socioeconomic or
cultural.
An algorithm to target women at high
risk for postpartum glucose intolerance
mightensurethatthemajorityofpostpar-
tum diabetes is identiﬁed. Ideally, it
should be possible to calculate the indi-
vidual risk of each woman for diabetes
duringtheearlypostpartumperiodbased
on easily available antenatal risk factors.
Based on the prevalence of abnormal
ppOGTTs according to the number of
risk factors present, we deﬁned three risk
categories. Women with low risk (OR
1.3) had a low prevalence of abnormal
ppOGTTs(11%),whereasinwomenwith
intermediate or high risk we expect to see
36% with persistent glucose intolerance.
These women accounted for 40% of our
population,buttherateofwomenathigh
risk may vary in other populations de-
pending, for example, on the obesity and
underlying type 2 diabetes prevalence. If
our model of risk factor–based postpar-
tumscreeningholdsinotherpopulations,
we would detect 86% of postpartum dia-
betes by focusing on intensive counseling
and following women who are likely to
remain diabetic. Concentrating our ef-
forts on motivating these women to re-
turn for testing and developing a system
of cooperation with other caregivers, e.g.,
the pediatrician who sees the children,
might reduce the number of missed cases
of postpartum diabetes. Missing the op-
portunity to identify pre-diabetes or dia-
betes in underserved women may mean
thatdiabetesisnotidentiﬁeduntilamuch
later stage than in women who access
health care.
The limitation of our study is that we
do not have information about the post-
partum glucose tolerance status of all of
the women who did not return for post-
partum testing. We have relatively com-
plete data for two centers, but because of
the low return rates in Berlin, the inci-
dence of abnormal ppOGTTs might be
overestimated. Because nonreturners at
the site with a low return rate were not
different from returners regarding risk
factors for diabetes we consider our re-
sults to be representative for the whole
Figure1—PrevalenceofabnormalpostpartumglucosetoleranceinwomenafterGDMdividedby
the number of risk factors present. There was a signiﬁcant increase in abnormal postpartum
glucosetolerancebetweenwomenwithlowrisk(2riskfactors)andintermediate(2riskfactors)
(P  0.001), and intermediate (2 risk factors) and high risk (2 risk factors) (P  0.001).
Figure 2—Proportion of subjects stratiﬁed by the number of independent risk factors: low-risk
group(2riskfactors),intermediate-riskgroup(2riskfactors),andhigh-riskgroup(3or4risk
factors). The risk of an abnormal ppOGTT is estimated by OR (95% CI) according to the risk in
153subjectswithoutanypositivefactor.Overall86.2%oftheovertdiabetes(25of29)and67.8%
of all abnormal OGTTs (82 of 121) were identiﬁed within the intermediate/high-risk group.
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with prospective use of our model in dif-
ferent populations have to be conducted
to prove the validity and transferability of
our data.
Consideringthehighrateofearlyglu-
cose intolerance, it is imperative that we
ensure that women who develop GDM
understand that glucose intolerance may
persist or return after pregnancy and that
this risk for diabetes can be modiﬁed by
lifestyle changes (6), and, therefore, post-
partum testing is essential. However,
widespread implementation of ppOGTT
is difﬁcult. The model of risk assessment
we presented, which is based on easily
available antenatal data, may allow us to
target women with a high need of inten-
sive motivation for postpartum testing
and therefore may offer a chance to re-
duce the number of missed cases of post-
partum diabetes in women with recent
GDM.
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